世界の気道管理チューブ市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

気道管理チューブ市場分析

気道管理チューブ市場は、呼吸器疾患に対処し、救命救急をサポートするための効率的で高度なソリューションに対する需要の高まりに牽引され、堅調な成長を遂げています。麻酔管理、救急医療、集中治療室に不可欠なこれらのチューブは、医療処置中に気道を確保します。慢性閉塞性肺疾患（COPD）や喘息などの慢性呼吸器疾患の罹患率の上昇により、これらのデバイスの必要性が大幅に高まっています。世界保健機関によると、2019年には世界中で2億6,200万人以上が喘息に罹患しており、高度な気道管理ソリューションの緊急の必要性が強調されています。この分野における技術の進歩は市場に革命をもたらしており、ビデオガイド付き挿管システム、強化チューブ、使い捨てソリューションなどのイノベーションにより、精度、感染リスクの低減、患者の安全性の向上が保証されています。たとえば、ビデオ喉頭鏡と気道チューブを統合すると、リアルタイムの視覚化が可能になり、重要な状況や緊急の状況での手順の精度が向上します。新興市場、特にアジア太平洋地域では、医療投資とインフラ開発の増加により、有利な機会が生まれています。呼吸ケアの継続的な進歩と意識の高まりにより、気道管理チューブ市場は持続的な成長を遂げ、世界中の多様な医療ニーズに応えられる態勢が整っています。

気道管理チューブ市場規模

世界の気道管理チューブ市場規模は、2024年に2億9,195万米ドルと評価され、2025年から2032年の予測期間中に4.41%のCAGRで成長し、2032年には4億1,234万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

気道管理チューブの市場動向

「単回使用および使い捨ての気道管理デバイスの使用の増加」

気道管理チューブ市場では、感染管理と患者の安全に対する懸念の高まりにより、単回使用および使い捨ての気道管理デバイスへの大きなシフトが起きています。この傾向は、COVID-19パンデミックにより交差汚染と院内感染のリスクが高まっている医療現場で特に顕著です。使い捨ての気道チューブは感染リスクを最小限に抑えるように設計されているため、緊急時と日常的な医療処置の両方で好まれる選択肢となっています。たとえば、Ambu A/Sなどの企業は、費用対効果が高く環境に配慮した単回使用の光ファイバー挿管チューブを導入し、医療廃棄物管理における持続可能性の懸念に対処しています。この傾向は、患者の転帰を改善するために滅菌された単回使用の機器を強調する規制勧告によっても後押しされています。材料科学の進歩により耐久性がありながら使い捨てのソリューションが可能になったことで、市場は衛生プロトコルを強化して患者ケアを最適化する世界的な取り組みと足並みを揃え、気道管理チューブセグメントの持続的な成長と革新を推進しています。

レポートの範囲と気道管理チューブ市場のセグメンテーション 

気道管理チューブ市場の定義

気道管理チューブは、呼吸補助が必要な患者の気道を確保するために使用する医療機器です。これらのチューブは、酸素の供給と二酸化炭素の除去を容易にするために呼吸器に挿入され、手術、緊急処置、または集中治療中に適切な換気を確保します。一般的な気道管理チューブには、口または鼻から気管に挿入される気管内チューブと、長期的な気道サポートのために気管の開口部に直接配置される気管切開チューブがあります。

気道管理チューブ市場の動向

ドライバー

• 呼吸器疾患の発生率増加

呼吸器疾患の発生率の増加は、気道管理チューブ市場の大きな推進力となっています。世界保健機関 (WHO) によると、慢性閉塞性肺疾患 (COPD) や喘息などの慢性呼吸器疾患は、世界中で 9 億人以上に影響を与えており、主な死因の 1 つとなっています。こうした疾患では、効果的な気流と酸素供給を維持するために、補助換気や挿管などの医療介入が必要になることが多く、この罹患率の増加により気道管理ソリューションの需要が高まっています。さらに、米国疾病管理予防センター (CDC) のデータによると、肺炎は、特に高齢者や基礎疾患のある人々の間で、依然として入院の主な原因となっています。緊急医療処置と日常医療処置の両方で患者ケアをサポートする、信頼性が高く、安全で効果的な気道管理チューブの必要性が、市場の成長を後押ししています。

• 高齢化人口の増加

高齢者人口の増加は、気道管理チューブ市場の主要な推進力となっています。高齢者は呼吸器系の問題を抱えやすく、気道サポートを伴う外科的介入が必要になることが多いためです。国連によると、60歳以上の世界人口は、2020年の10億人から2050年までに21億人に達すると予測されています。高齢化に伴い、COPDや肺炎などの慢性呼吸器疾患の発生率が高くなるほか、挿管や人工呼吸器補助を必要とする手術が増えるため、この人口動態の変化は重要です。たとえば、米国国勢調査局の報告によると、米国だけでも65歳以上の人口は2020年の約5,600万人から2060年までに9,400万人以上に増加すると予想されています。高齢者人口の増加により、医療処置中に安全な呼吸と換気を確保するための信頼性が高く効果的な気道管理ソリューションの需要が高まり、市場の成長に貢献しています。

機会

• 技術の進歩の加速

技術の進歩により、気道管理チューブ市場に大きなチャンスが生まれています。最新のデバイスには、患者の安全性と手順の効率性を向上させる機能が搭載されているからです。誤嚥防止カフなどの革新技術は、誤嚥性肺炎の予防に役立ちます。また、統合モニタリング システムにより、患者の気道状態をリアルタイムで評価できるため、手術中の意思決定が向上します。たとえば、生体適合性材料はアレルギー反応や合併症のリスクを軽減し、デバイスをより患者に優しいものにします。そのような進歩の 1 つは、気道チューブの設計に高度な材料を使用することです。これにより、耐久性が向上し、使用中の損傷のリスクが最小限に抑えられます。さらに、圧力を監視し、潜在的な問題を医療従事者に警告するセンサーなどのスマート テクノロジーの組み込みにより、気道管理の実践に革命が起こりました。これらの進歩は、患者の転帰を改善するのに役立つため、病院や手術センターで急速に採用されており、高性能な気道管理ソリューションに対する高まる需要に対応しようとしている医療機器メーカーにとって、有利な市場機会となっています。

• 医療機器の品質の継続的な改善

The continuous improvement of the quality of healthcare equipment presents a significant market opportunity, especially for airway management tubes. Enhanced materials, better manufacturing processes, and stringent quality control measures have led to the development of more reliable and safer medical devices. For instance, the use of high-grade medical silicone and other biocompatible materials in airway management tubes has reduced the risk of tissue damage and infections, improving patient comfort and recovery times.  In addition, advancements such as reinforced tubes that minimize kinking and allow for smoother intubation contribute to better procedural outcomes. The emphasis on quality improvement is also reflected in the adoption of certifications and regulatory approvals, which further assure hospitals and clinics of the equipment’s safety and efficacy. As healthcare providers increasingly prioritize patient safety and operational efficiency, investments in high-quality airway management tubes are on the rise, presenting opportunities for manufacturers to meet these evolving standards and expand their market presence.

Restraints/Challenges

• Strict Regulatory Compliances

Regulatory compliance is a significant challenge in the airway management tubes market, as meeting the stringent safety and quality standards set by regulatory bodies such as the FDA, CE, and other national health authorities can be both complex and costly. Manufacturers must undergo extensive testing, provide thorough documentation, and demonstrate adherence to protocols that ensure patient safety, all of which can delay product launches and substantially increase development expenses. For instance, in the United States, the FDA requires medical device manufacturers to submit comprehensive data, including clinical trial results and detailed reports on product performance, before approval can be granted. This rigorous process can be particularly challenging for smaller manufacturers that lack the resources to conduct the required research and navigate the complex regulatory landscape. Failure to meet these standards can result in regulatory penalties, product recalls, or denial of market entry, which can damage a company’s reputation and lead to financial losses. As such, regulatory compliance remains a crucial market challenge, emphasizing the need for strategic planning, investment in compliance expertise, and effective collaboration with regulatory bodies to ensure timely and successful product launches.

• High Production Costs

High production costs present a major challenge in the airway management tubes market, as the manufacturing of advanced devices often involves the use of specialized materials and sophisticated technologies that increase expenses. Features such as anti-fog coatings, reinforced structures for durability, or smart sensors for real-time monitoring contribute significantly to the overall production costs. For instance, airway tubes with integrated sensors that monitor and transmit real-time data on air flow and pressure can greatly enhance patient safety but come at a higher price point. These elevated costs can limit the adoption of such advanced products, especially in regions with budget constraints or underfunded healthcare systems. In low-income or developing areas, hospitals may prioritize basic, less expensive airway management solutions over advanced models due to financial limitations, which can impact patient outcomes and overall market growth. This challenge underscores the need for manufacturers to balance the integration of advanced features with cost-effective production strategies, such as leveraging more affordable yet high-quality materials or optimizing manufacturing processes, to make these devices accessible to a broader range of healthcare facilities and regions.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Airway Management Tubes Market Scope

The market is segmented on the basis of type, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Supraglottic Device
• Infraglottic Device
• Resuscitators
• Laryngoscopes

Application

• Anesthesia
• Emergency Medicine

End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Airway Management Tubes Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is the dominant region in the airway management tubes market, driven by significant technological advancements and a well-established healthcare infrastructure. The region benefits from the presence of highly skilled surgeons and advanced medical facilities, ensuring superior patient care.  In addition, the high prevalence of chronic obstructive pulmonary diseases (COPD) and other respiratory conditions further amplifies the demand for airway management devices. These factors collectively position North America as a leader in the market, setting a benchmark for innovation and healthcare standards.

Asia-Pacific is rapidly emerging as a lucrative market for airway management tubes, driven by a growing population and significant infrastructural upgrades in the healthcare sector. Between 2025 and 2032, the region is expected to witness robust growth as established market players increasingly focus on expanding their presence in these dynamic economies. Factors such as rising investments in healthcare infrastructure, government initiatives to enhance medical facilities, and the increasing demand for advanced medical devices are fueling market expansion. This makes Asia-Pacific a key focal point for global companies aiming to capture untapped opportunities in the airway management sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Airway Management Tubes Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Airway Management Tubes Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• ICU Medical, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• Ambu A/S (Denmark)
• KARL STORZ (Germany)
• Flexicare (Group) Limited (U.K.)
• Verathon Inc. (U.S.)
• Olympus Corporation (Japan)
• Intersurgical Ltd (U.K.)
• SunMED Medical (U.S.)
• Vyaire (U.S.)
• BD (U.S.)
• Fisher and Paykel Healthcare Limited (New Zealand)
• Cook (U.S.)
• Atos Medical (Sweden)
• Pulmodyne, Inc. (U.S.)
• FUJI SYSTEMS, INC (Japan)
• Mercury Medical (U.S.)
• Armstrong Medical Ltd (U.K.)

Latest Developments in Airway Management Tubes Market

• In September 2023, Verathon introduced the GlideScope Go 2, an advanced handheld video laryngoscope designed to improve airway management in urgent and critical care settings. The device features QuickConnect technology for seamless operation, allowing clinicians to prioritize patient care. Now available in the U.S., this next-generation product underscores Verathon’s dedication to innovative airway management solutions that support first-pass success in challenging environments
• In June 2023, Teleflex Incorporated entered into an exclusive U.S. distribution partnership with Shenzhen Insighters Medical Technology Co., Ltd. for the Insighters® Video Laryngoscope system. This advanced airway management device aids in endotracheal intubation and upper glottic airway inspection, with interchangeable components for real-time high-resolution video sharing. The partnership aligns with the American Society of Anesthesiologists Difficult Airway Algorithm, enhancing patient safety and clinical outcomes
• In January 2022, Intersurgical Ltd acquired Pulmodyne, Inc., a U.S. and Malaysian-based manufacturer of airway and respiratory products. This acquisition strengthens Intersurgical’s presence in the U.S. market and expands its global distribution network, increasing sales of Pulmodyne's innovative products for prehospital, emergency, and critical care
• In May 2021, Teleflex Incorporated and Medline Industries, Inc. signed an agreement for Teleflex to acquire non-invasive ventilation products, which deliver ventilation support through the upper airway using masks or similar devices. The acquisition supports Teleflex’s growth strategy by enhancing financial flexibility and expanding its product portfolio
• In March 2021, Convatec Group PLC announced the acquisition of Cure Medical, LLC, merging two innovative manufacturers of continence care products. This collaboration enhances their range of products and services for managing chronic conditions, offering a more comprehensive solution to patients and healthcare providers

SKU-64029